May 27, 2026 Palleon Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of E-688/HLX316, a First-in-Class B7-H3-Targeted Sialidase for Advanced Solid Tumors
May 27, 2026 Fortem Technologies Establishes Government Advisory Board Led by MG (Ret.) Clay Hutmacher
May 27, 2026 Redfin Reports 29% of U.S. Homebuyers Paid Cash in March—the Lowest Share For That Month Since 2020
May 27, 2026 Kemper Announces Appointment of Stephen J. McAnena as President, Chief Executive Officer and Board Member
